Mirca Lazzaretti

3.2k total citations
43 papers, 2.1k citations indexed

About

Mirca Lazzaretti is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Mirca Lazzaretti has authored 43 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 21 papers in Hematology and 17 papers in Oncology. Recurrent topics in Mirca Lazzaretti's work include Multiple Myeloma Research and Treatments (20 papers), Bone health and treatments (9 papers) and Ubiquitin and proteasome pathways (6 papers). Mirca Lazzaretti is often cited by papers focused on Multiple Myeloma Research and Treatments (20 papers), Bone health and treatments (9 papers) and Ubiquitin and proteasome pathways (6 papers). Mirca Lazzaretti collaborates with scholars based in Italy, France and United States. Mirca Lazzaretti's co-authors include Nicola Giuliani, Sabrina Bonomini, Vittorio Rizzoli, Cristina Mancini, Régis Bataille, Sophie Barillé‐Nion, Simona Colla, Francesca Morandi, Roberto Sala and Sara Tagliaferri and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Mirca Lazzaretti

43 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mirca Lazzaretti Italy 22 1.2k 1.0k 974 205 197 43 2.1k
Makoto Hamasaki Japan 31 628 0.5× 982 1.0× 287 0.3× 216 1.1× 267 1.4× 120 2.7k
Jin Yuan China 28 383 0.3× 1.4k 1.3× 557 0.6× 271 1.3× 279 1.4× 71 2.5k
Roberta Riccioni Italy 23 523 0.4× 1.4k 1.3× 812 0.8× 302 1.5× 461 2.3× 45 2.1k
Jeena Joseph India 17 864 0.7× 722 0.7× 164 0.2× 373 1.8× 285 1.4× 41 1.8k
Keisuke Kataoka Japan 31 683 0.6× 1.2k 1.1× 877 0.9× 309 1.5× 718 3.6× 145 3.0k
Farideh Sabeh United States 17 905 0.8× 866 0.8× 285 0.3× 1.2k 5.7× 178 0.9× 25 2.6k
Jennifer J. Westendorf United States 23 792 0.7× 2.5k 2.5× 248 0.3× 474 2.3× 128 0.6× 31 3.2k
Alexis Grande Italy 25 310 0.3× 824 0.8× 280 0.3× 132 0.6× 415 2.1× 70 1.6k
Alessandro Isidori Italy 26 769 0.6× 626 0.6× 1.1k 1.2× 108 0.5× 743 3.8× 89 2.4k
Yoshiki Yamada Japan 16 885 0.7× 1.9k 1.8× 126 0.1× 357 1.7× 303 1.5× 33 2.5k

Countries citing papers authored by Mirca Lazzaretti

Since Specialization
Citations

This map shows the geographic impact of Mirca Lazzaretti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mirca Lazzaretti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mirca Lazzaretti more than expected).

Fields of papers citing papers by Mirca Lazzaretti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mirca Lazzaretti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mirca Lazzaretti. The network helps show where Mirca Lazzaretti may publish in the future.

Co-authorship network of co-authors of Mirca Lazzaretti

This figure shows the co-authorship network connecting the top 25 collaborators of Mirca Lazzaretti. A scholar is included among the top collaborators of Mirca Lazzaretti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mirca Lazzaretti. Mirca Lazzaretti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lazzaretti, Mirca, et al.. (2025). A translational perspective of the malignant hematopoietic proteoglycome. Cell & Bioscience. 15(1). 25–25. 2 indexed citations
2.
Bisceglie, Franco, et al.. (2023). Modulation of Transcription Profile Induced by Antiproliferative Thiosemicarbazone Metal Complexes in U937 Cancer Cells. Pharmaceutics. 15(5). 1325–1325. 4 indexed citations
3.
Dallabona, Cristina, et al.. (2015). Modeling human Coenzyme A synthase mutation in yeast reveals altered mitochondrial function, lipid content and iron metabolism. Microbial Cell. 2(4). 126–135. 21 indexed citations
4.
5.
Storti, Paola, Marina Bolzoni, Gaetano Donofrío, et al.. (2013). Hypoxia-inducible factor (HIF)-1α suppression in myeloma cells blocks tumoral growth in vivo inhibiting angiogenesis and bone destruction. Leukemia. 27(8). 1697–1706. 89 indexed citations
6.
7.
Storti, Paola, Gaetano Donofrío, Simona Colla, et al.. (2010). HOXB7 expression by myeloma cells regulates their pro-angiogenic properties in multiple myeloma patients. Leukemia. 25(3). 527–537. 38 indexed citations
8.
Rizzi, Federica, L Belloni, Pellegrino Crafa, et al.. (2008). A Novel Gene Signature for Molecular Diagnosis of Human Prostate Cancer by RT-qPCR. PLoS ONE. 3(10). e3617–e3617. 42 indexed citations
9.
Ferrari, Maurizio, et al.. (2007). Adult Stem Cells: Perspectives for Therapeutic Applications. Veterinary Research Communications. 31(S1). 1–8. 12 indexed citations
10.
Giuliani, Nicola, Francesca Morandi, Sara Tagliaferri, et al.. (2007). Production of Wnt Inhibitors by Myeloma Cells: Potential Effects on Canonical Wnt Pathway in the Bone Microenvironment. Cancer Research. 67(16). 7665–7674. 81 indexed citations
11.
Musolino, Antonino, Annamaria Guazzi, Mirca Lazzaretti, et al.. (2007). Intracranial hematopoiesis in a patient with aids-related central nervous system lymphoma and severe pancytopenia. Haematologica. 92(5). e59–e61. 8 indexed citations
12.
13.
Menozzi, Alessandro, Cristina Pozzoli, E. Poli, et al.. (2006). Long-term study of TNBS-induced colitis in rats: Focus on mast cells. Inflammation Research. 55(10). 416–422. 23 indexed citations
14.
Giuliani, Nicola, Francesca Morandi, Sara Tagliaferri, et al.. (2006). The Proteasome Inhibitor Bortezomib Affects Osteoblastogenesis and Bone Formation In Vitro and In Vivo in Multiple Myeloma Patients.. Blood. 108(11). 508–508. 3 indexed citations
15.
Menozzi, Alessandro, Cristina Pozzoli, Enzo Poli, et al.. (2005). Effect of the Macrolide Antibacterial Drug, Tylosin, on TNBS-Induced Colitis in the Rat. Pharmacology. 74(3). 135–142. 14 indexed citations
16.
Carlinfante, Gabriele, Mirca Lazzaretti, Silvano Ferrari, Bernardo Bianchi, & Pellegrino Crafa. (2005). p53, bcl-2 and Ki-67 expression in adenoid cystic carcinoma of the palate. A clinico-pathologic study of 21 cases with long-term follow-up. Pathology - Research and Practice. 200(11-12). 791–799. 34 indexed citations
17.
Colla, Simona, Francesca Morandi, Mirca Lazzaretti, et al.. (2005). Human myeloma cells express the bone regulating gene Runx2/Cbfa1 and produce osteopontin that is involved in angiogenesis in multiple myeloma patients. Leukemia. 19(12). 2166–2176. 59 indexed citations
18.
Manganelli, P, Nicola Giuliani, Pieranna Fietta, et al.. (2004). OPG/RANKL system imbalance in a case of hepatitis C-associated osteosclerosis: the pathogenetic key?. Clinical Rheumatology. 24(3). 296–300. 30 indexed citations
19.
Morini, Giuseppina, Elena Guaita, Mirca Lazzaretti, Daniela Grandi, & Gabriella Coruzzi. (2003). Morphological Features of Rat Gastric Mucosa after Acute and Chronic Treatment with Amtolmetin Guacyl: Comparison with Non-Selective and COX-2-Selective NSAIDs. Digestion. 68(2-3). 124–132. 4 indexed citations
20.
Giuliani, Nicola, Régis Bataille, Cristina Mancini, Mirca Lazzaretti, & Sophie Barillé‐Nion. (2001). Myeloma cells induce imbalance in the osteoprotegerin/osteoprotegerin ligand system in the human bone marrow environment. Blood. 98(13). 3527–3533. 302 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Makoto Hamasaki Breakdown of academic impact, for papers by Jin Yuan Breakdown of academic impact, for papers by Roberta Riccioni Breakdown of academic impact, for papers by Jeena Joseph Breakdown of academic impact, for papers by Keisuke Kataoka Breakdown of academic impact, for papers by Farideh Sabeh Breakdown of academic impact, for papers by Jennifer J. Westendorf Breakdown of academic impact, for papers by Alexis Grande Breakdown of academic impact, for papers by Alessandro Isidori Breakdown of academic impact, for papers by Yoshiki Yamada
Rankless by CCL
2026